Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Risk factors for respiratory failure in pneumococcal pneumonia. The importance of pneumococcal serotypes

Joaquín Burgos, Manel Luján, MªNieves Larrosa, Dionísia Fontanals, Guadalupe Bermudo, Ana Mª Planes, Mireia Puig, Jordi Rello, Vicenç Falcó, Albert Pahissa
European Respiratory Journal 2013; DOI: 10.1183/09031936.00050413
Joaquín Burgos
*Infectious Diseases Dept. Hospital Universitari Vall d'Hebron. Vall d'Hebron Research Institute (VHIR). Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jburgos@vhebron.net
Manel Luján
#Pneumology Dept. Hospital de Sabadell. Corporació Sanitaria Parc Taulí. Universitat Autònoma de Barcelona, Spain
¶CIBER Enfermedades Respiratorias (CIBERES), Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MªNieves Larrosa
+Microbiology Dept. Hospital Universitari Vall d'Hebron. Vall d'Hebron Research Institute (VHIR). Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dionísia Fontanals
§Microbiology Dept. UDIAT. Hospital de Sabadell. Corporació Sanitaria Parc Taulí. Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guadalupe Bermudo
#Pneumology Dept. Hospital de Sabadell. Corporació Sanitaria Parc Taulí. Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Mª Planes
¶CIBER Enfermedades Respiratorias (CIBERES), Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mireia Puig
*Infectious Diseases Dept. Hospital Universitari Vall d'Hebron. Vall d'Hebron Research Institute (VHIR). Universitat Autònoma de Barcelona, Spain
fSpanish Network for Research in Infectious Diseases (REIPI)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordi Rello
¶CIBER Enfermedades Respiratorias (CIBERES), Spain
**Critical Care Dept. Hospital Universitari Vall d'Hebron. Vall d'Hebron Research Institute (VHIR). Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vicenç Falcó
*Infectious Diseases Dept. Hospital Universitari Vall d'Hebron. Vall d'Hebron Research Institute (VHIR). Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Pahissa
*Infectious Diseases Dept. Hospital Universitari Vall d'Hebron. Vall d'Hebron Research Institute (VHIR). Universitat Autònoma de Barcelona, Spain
fSpanish Network for Research in Infectious Diseases (REIPI)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Pneumococcal serotypes are one of the main determinants of pneumococcal disease severity, however there are scarce data about their implication in respiratory failure.

We conducted an observational study of adults hospitalised with invasive pneumococcal pneumonia to describe the host- and pathogen-related factors associated with respiratory failure.

Of 1258 adults with invasive pneumococcal disease, 615 (48.9%) had respiratory failure at presentation. Patients with respiratory failure were older (62.1 vs. 55.4, p<.001) and had a greater proportion of co-morbid conditions. They also had a greater proportion of septic shock (41.7% vs. 6.1%, p<.001), required more often ICU admission (38.4% vs. 4.2%, p<.001) and had a higher mortality (25.5% vs. 3.5%, p<.001). After adjustment, independent risk factors for respiratory failure were: age >50 years (OR 1.63; 95% CI, 1.15–2.3), chronic lung disease (OR 1.54; 95% CI, 1.1–2.15), chronic heart disease (OR 1.49; 95% CI, 1.01–2.22) infection caused by serotypes 3 (OR 1.97; 95% CI, 1.23–3.16), 19A (OR 2.34; 95% CI, 1.14–4.42) and 19F (OR 3.55; 95% CI, 1.22–10.28).

In conclusion, respiratory failure is a frequent complication of pneumococcal pneumonia and causes high morbidity and mortality. Pneumococcal serotypes 3, 19A and 19F are the main risk factors for this complication.

  • Acute respiratory failure
  • pneumococcal disease
  • streptococcus pneumonia
  • ERS
Next
Back to top
Vol 57 Issue 2 Table of Contents
European Respiratory Journal: 57 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk factors for respiratory failure in pneumococcal pneumonia. The importance of pneumococcal serotypes
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Risk factors for respiratory failure in pneumococcal pneumonia. The importance of pneumococcal serotypes
Joaquín Burgos, Manel Luján, MªNieves Larrosa, Dionísia Fontanals, Guadalupe Bermudo, Ana Mª Planes, Mireia Puig, Jordi Rello, Vicenç Falcó, Albert Pahissa
European Respiratory Journal Jan 2013, erj00504-2013; DOI: 10.1183/09031936.00050413

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Risk factors for respiratory failure in pneumococcal pneumonia. The importance of pneumococcal serotypes
Joaquín Burgos, Manel Luján, MªNieves Larrosa, Dionísia Fontanals, Guadalupe Bermudo, Ana Mª Planes, Mireia Puig, Jordi Rello, Vicenç Falcó, Albert Pahissa
European Respiratory Journal Jan 2013, erj00504-2013; DOI: 10.1183/09031936.00050413
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients
  • Point-of-care lung ultrasound assessment for risk stratification and therapy guiding in COVID-19 patients. A prospective non-interventional study
  • Expectation and dyspnea: The neurobiological basis of respiratory nocebo effects
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society